Cipla is amongst the leading pharmaceuticals having a significant presence in two key markets – Indian and the US. It is chiefly known for respiratory therapies due which its products were is in demand during COVID pandemic. It commands a sizeable share in chronic therapies, with a presence in cardiovascular, diabetic and respiratory therapies.
#stocks #cipla #stockmarket
Moneycontrol is India’s leading financial and business portal with in-depth market coverage, analysis, expert opinions, and a gamut of financial tools.
A part of Network18, moneycontrol.com is the most influential destination for stock market news and advice, business news, and news about the Indian and global economy.
Subscribe:
Follow us:
Visit
Facebook:
Twitter:
Instagram:
We are a group of best insurance advisors in Delhi. We are experts in LIC and have received number of awards.
If you are near Delhi or Rohini or Pitampura Contact Us Here
———————————————————————
———————————————————————
About the Channel-
This channel MyCompany provides review videos for all demat accounts, trading apps, and investment apps.
Our content rotates around the Pros and cons of investment apps, trading apps, and demat accounts so that we can give you an honest and balanced review about any platform or app under review.
Apart from Pros and cons We also cover eligibility criteria and charges associated with that app or demat/trading account.
Our vision is to make the financial world more transparent and simplified for the common public.
———————————————————————
———————————————————————
Follow us for more -
1. We are not SEBI registered Advisors, any stock analysis video is not a direct buy/sell recommendation, please do your own research before taking any investment decision. The purpose of this channel is only to Educate you about stock investing.
2. This video is for educational purposes only. Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowances are made for “fair use” for purposes such as criticism, comment, news reporting, teaching scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational, and personal use tips the balance in favor of fair use.
We are a group of best insurance advisors in Delhi. We are experts in LIC and have received number of awards.
If you are near Delhi or Rohini or Pitampura Contact Us Here
Insurance Act Amendment Bill | Non Life Insurance Latest News | Business News Hindi | ET Now Swadesh |
बीमा कानूनों को लेकर बड़ी खबर है कि, नॉन लाइफ इन्शुरन्स ने वित्त मंत्रालय को पत्र लिखकर बीमा कंपनियों के लाइसेंस पर विरोध जताया है। Insurance Act में बड़े बदलावो करने के लिए वित्त मंत्रालय ने ड्राफ़्ट के जरिए सभी कंपनियों से सुझाव मांगे थे। इस दौरान नॉन लाइफ इंश्योरेंस कंपनियों ने कंपोजिट लाइसेंस, न्यूनतम कैपिटल पर आपत्ति जताई है। ज्यादा जानकारी के लिए देखिए पूरी खबर
#NonLifeInsurance #InsuranceAct #MarketWithSwadesh
————————————————————————————————————-
Subscribe to our channel:
Download our mobile app:
Watch Live TV :
Subscribe to our other network channels:
Times Now:
Zoom:
————————————————————————————————————-
You can also visit our website at:
Like us on Facebook:
Follow us on Twitter:
Follow us on Instagram:
Follow us on Google News for latest updates
Times Now Navbharat:
Times Now :
Zoom:
The sharp revival in equity markets has catalysed the primary markets, and as many as 27 companies have filed offer documents with the Securities and Exchange Board of India (SEBI) over the last couple of months.
With foreign portfolio investors (FPIs) making a strong comeback — the benchmark Sensex has reclaimed the 60,000 mark — merchant bankers have lined up public issues to take advantage of bullish domestic retail and FPI investor sentiments. While there has been no new listing since May 24, the cycle is set to restart with the listing of Syrma SGS Technology later this month. The issue closed for subscription on Thursday. Many more are lined up — Utkarsh Small Finance Bank, Fincare Small Finance Bank, and GO Digit General Insurance have filed their offer documents with SEBI.
How are the IPOs that came during the previous market boom faring?
2021 witnessed a record number of IPOs and fund-raising. While 63 companies came with public issues to raise funds amounting to a record Rs 118,723 crore from the equity markets in the calendar year, only 18 issues have hit the market in 2022. Collectively, they have raised Rs 40,310 crore — and half of this amount has come from just one issue: LIC.
A large number of public issues that hit the market amid soaring valuation in 2021 are now trading below their issue price. Data from NSE show that 27 of the 63 issues that hit the market in 2021 are trading below their issue price, including high-profile ones such as One 97 Communication (Paytm) and Zomato.
On the other hand, of the 16 issues that hit the market in calendar 2022 when the markets were less buoyant and the indices were on a decline, only four are trading below the issue price.
“We always witness a bunching-up of issues when the secondary market is buoyant. Most issues that come in times of sharp rally in the markets tend to be overpriced, and are susceptible to sharp declines when the market weakens. On the other hand, IPOs that come during normal times fare much better as they tend to be priced reasonably,” a fund manager who did not wish to be named, said.
So should you invest in this IPO rush?
The 18 per cent rally in the benchmark indices at the BSE and NSE since June 17, coming on the back of sharp FPI flows and a revival in investor sentiment, have encouraged merchant bankers to line up issues. For retail investors looking to play in the primary market, however, experts advise caution. They say that retail investors should seek out good-quality stocks from the bouquet of existing listed companies, and pick up the ones that are undervalued and not leveraged.
Several high-profile new age tech companies that came with their issues in 2021 are trading below their offer price — market participants say investors should be cautious, as there is a lot of irrationality around start-ups when there is liquidity in the market.
“When the market weakens, investor confidence in these companies gets shaken even on minor negative news flows. In the case of most of these companies where profitability is not visible for the next five years, it is very tough for an investor to stay invested when the market weakens, and so one has to be very careful about which company and at what valuation they are investing,” the head of research with financial services firm said.
What should you look for before investing in an IPO?
An IPO is an asset class that is a derivative of the secondary market, and its performance is linked to the sentiment in the broader market. Demand tends to be strong when investor sentiment is buoyant, and in such a scenario they get higher investor interest and fare well. However, that is not true for all cases; it also depends upon the pricing of the issue. Hence, investors need to do a thorough study of the company — the quality of promoters, business fundamentals, and the financial and peer review analysis — before investing in an IPO.
Corporate governance practices in the company should be given top priority. A good peer review is a must: Investors must study other listed companies in the sector and compare their growth, and their PE ratio (market price to earnings per share). If the company coming with an IPO is demanding a higher valuation, investors can consider avoiding it.
For more information call us at 9891563359.
We are a group of best insurance advisors in Delhi. We are experts in LIC and have received number of awards.
If you are near Delhi or Rohini or Pitampura Contact Us Here
The company’s weak listing can be attributed to high volatility in the markets and negative market sentiments. LIC enjoys many competitive advantages like strong brand value, extremely large scale of operations, a huge network of agents, and an envious distribution network, further, the company’s issue was priced at a price to embedded value of 1.1x, providing a valuation comfort, so we suggest investors to stay with the company for the long term despite the negative listing. Those who applied for listing gains can maintain a stop loss of Rs. 800. New investors can take advantage of the dips to accumulate this share for the long term. We would like to add that the company’s further downside will be limited due to low float post listing.
For more information call us at 9891563359.
We are a group of best insurance advisors in Delhi. We are experts in LIC and have received number of awards.
If you are near Delhi or Rohini or Pitampura Contact Us Here
LIC IPO में INVEST ना करे? Review of LIC –
.
#LIC #LICIPO #Shorts #ShareMarket
.
The LIC IPO is likely to be the biggest initial public offering in the Indian stock market. The price band of the LIC IPO is yet to be announced.
.
The Government of India plans to launch the LIC IPO by this year’s last quarter. However, the tentative dates for the IPO events are yet to be disclosed. Life Insurance Corporation of India is an investment and insurance corporation owned by the Government of India.
.
LIC is the only life insurance company in the Indian public sector with an extensive presence in rural and urban areas. It operates through 8 zonal and 113 divisional offices.
.
Like, Share & Subscribe for Upcoming Videos
.
Stay Connected
Twitter –
Facebook –
Instagram –
Zee Business is India’s Number 1 Hindi business news channel. It’s your channel for profit and wealth. Watch Live coverage of Indian markets – Sensex & Nifty, also for expert insights and advise from our team of experts.
————————————————————–
You can also visit us at:
Like us on Facebook:
Follow us on Twitter:
Subscribe to our other network channels:
Zee News:
